| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Moderna, Inc. | General Counsel and Secretary | Common Stock | 901 | $93.6K | $103.90 | May 27, 2021 | Direct |
| Moderna, Inc. | General Counsel and Secretary | Stock Option (Right to Buy) | 328K | May 27, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | May 27, 2021 | 3 | -$1.05M | 4 | May 28, 2021 | General Counsel and Secretary |
| MRNA | Moderna, Inc. | May 25, 2021 | 3 | -$1M | 4 | May 27, 2021 | General Counsel and Secretary |
| MRNA | Moderna, Inc. | May 20, 2021 | 3 | -$957K | 4 | May 21, 2021 | General Counsel and Secretary |
| MRNA | Moderna, Inc. | May 18, 2021 | 3 | -$959K | 4 | May 20, 2021 | General Counsel and Secretary |
| MRNA | Moderna, Inc. | May 13, 2021 | 3 | -$909K | 4 | May 14, 2021 | General Counsel and Secretary |
| MRNA | Moderna, Inc. | May 11, 2021 | 5 | -$898K | 4 | May 13, 2021 | General Counsel and Secretary |
| MRNA | Moderna, Inc. | May 6, 2021 | 3 | -$837K | 4 | May 7, 2021 | General Counsel and Secretary |